Spitzwieser and colleagues applied the MS-HRM method for detecting the methylated sites in MGMT, GSTP1, DAPK1, RASSF1A, CCND2, and HIN-1 promoters in breast cancer. Here, RASSF1 is linked to breast carcinoma.